Abstract
Purpose
Disorders of the hypothalamic-pituitary-thyroid axis are common in patients with acromegaly and thyroid enlargement is present in the majority of them. The exact prevalence of goiter in patients with acromegaly remains uncertain and the presence of thyroid autoimmunity has not been extensively evaluated so far.
Methods
We retrospectively evaluated thyroid biochemical and morphological findings in 116 acromegalic patients who attended our hospital. Serum TSH, total thyroxine levels and anti-thyroid peroxidase (ATPO) antibodies were measured by standard ultrasensitive techniques in all the patients. Thyroid ultrasound was performed in 75 out of them. The antibody control group was composed by healthy Argentinean individuals who attended the blood bank of our hospital in whom ATPO antibodies were measured.
Results
Twenty-nine out of the 116 acromegalic patients (25 %) showed elevated titers of thyroid antibodies (79 % were women and 21 % men). The control group had a 10 % prevalence of thyroid autoimmunity. The prevalence of goiter by ultrasound was 36 %, being more common in females (41 %) than in males (28 %). Thirty-five percent of patients who presented thyroid nodules and 44 % of patients with ultrasound diagnosed goiters had positive thyroid autoimmunity. There was no significant correlation between the presence of nodules and IGF-1 levels, duration of disease or age.
Conclusion
We found a high prevalence of thyroid autoimmunity in our patients with acromegaly as compared to the normal population. Thyroid autoimmunity seems to be an additional mechanism for the development of thyroid disorders in acromegaly.
Similar content being viewed by others
References
Eskildsen PC, Kruse A, Kirkegaard C (1988) The pituitary-thyroid axis. Horm Metab Res 20:755–757
Carmina E, Rosato F, Pirronello S, Janni A (1983) Hypothalamic-pituitary-thyroid axis in acromegaly. J Endocrinol Invest 6:263–266
Uchoa HB, Lima GA, Correa LL, Vidal AP, Cavallieri SA, Vaisman M, Buescu A, Gadelha MR (2013) Prevalence of thyroid diseases in patients with acromegaly: experience of a Brazilian Center. Arq Bras Endocrinol Metabol 57(9):685–690
Hegedus L, Perrild H, Poulsen LR, Andersen JR, Holm B, Schnohr P, Jensen G, Hansen JM (1983) The determination of thyroid volume by ultrasound and its relationship to body weight, age and sex in normal subjects. J Clin Endocrinol Metab 56:260–263
Gasperi M, Martino E, Manetti L, Arosio M, Porretti S, Faglia G, Mariotti S, Colao AM, Lombardi G, Baldelli R, Camanni F, Liuzzi A, Acromegaly Study Group of the Italian Society of Endocrinology (2002) Prevalence of thyroid diseases in patients with acromegaly: results of an Italian multi-center study. J Endocrinol Invest 25:240–245
Ishibashi M, Kuzuya N, Sawada S, Kitamura K, Kamoi K, Yamaji T (1991) Anti-thyroid antibodies in patients with hyperprolactinemia. Endocrinol Jpn 38(5):517–522
Cannavo S, Squadrito S, Finocchiaro MD, Curtò L, Almoto B, Vieni A, Trimarchi F (2000) Goiter and impairment of thyroid function in acromegalic patients: basal evaluation and follow-up. Horm Metab Res 32:190–195
Rogozinski A, Furioso A, Glikman P, Junco M, Laudi R, Reyes A, Lowenstein A (2012) Thyroid nodules in acromegaly. Arch Bras Endocrinol 56(5):300–304
Brunn J, Block U, Ruf G, Bos I, Kunze WP, Scriba PC (1981) Volumetric analysis of thyroid lobes by real-time ultrasound. Dtsch Med Wochenschr 106(41):1338–1340
Knudsen N, Bols B, Bulow I, Jorgensen T, Perrild H, Ovesen L, Laurberg P (1999) Validation of ultrasonography of the thyroid gland for epidemiological purposes. Thyroid 11:1069–1074
Niepomniszcze H, Pitoia F, Katz S, Chervin R, Bruno OD (2002) Primary thyroid disorders in endogenous Cushing’s syndrome. Eur J Endocrinol 147:305–311
Hollowell JG, Staehling NW, Flanders WD, Hannon WH, Gunter EW, Spencer CA, Braverman LE (2002) Serum TSH, T4, and thyroid antibodies in the United State’s population (1988–1994): National Health and Nutrition Examination Survey (NANHES III). J Clin Endocrinol Metab 87(32):489–499
Colao AM, Auriemma RS, Pivonello R, Galdiero M, Lombardi G (2008) Medical consequences of acromegaly: What are the effects of biochemical control? Rev Endocr Metab Disord 9:21–31
Barrere X, Valeix P, Preziosi P, Bensimon M, Pelletier B, Gallan P, Hercberg S (2000) Determinants of thyroid volume in healthy French adults participating in the SU.VI.MAX cohort. Clin Endocrinol (Oxf) 52(3):273–278
Herrmann BL, Baumann H, Janssen OE, Görges R, Schmid KW, Mann K (2004) Impact of disease activity on thyroid diseases in patients with acromegaly: basal evaluation and follow-up. Exp Clin Endocrinol Diabetes 112:225–230
Tita P, Ambrosio MR, Scollo C, Carta A, Gangemi P, Bondanelli M, Vigneri R, Degli Uberti EC, Pezzino V (2005) High prevalence of differentiated thyroid carcinoma in acromegaly. Clin Endocrinol 63:161–167
Smaniotto S, Martins-Neto AA, Dardenne M, Savino W (2011) Growth hormone is a modulator of lymphocyte migration. NeuroImmunoModulation 18(5):309–313
Savino W, Postel-Vinay MC, Smaniotto S, Dardenne M (2002) The thymus gland: a target organ for the growth hormone. Scand J Immunol 55(5):442–452
Savino W, Smaniotto S, Mendes-da-Cruz DA, Dardenne M (2012) Growth hormone modulates migration of thymocytes and peripheral T cells. Ann N Y Acad Sci 1261:49–54
Aghini-Lombardi F, Antonangeli L, Martino E, Vitti P, Maccherini D, Leoli F, Rago T, Grasso L, Valeriano R, Balestrieri A, Pinchera A (1999) The Spectrum of thyroid disorders in an iodine- deficient community: the pescopagano survey. J Clin Endocrinol Metab 84:561–566
Walsh JP, Bremner AP, Feddema P, Leedman PJ, Brown SJ, O’Leary P (2009) Thyrotropin and thyroid antibodies as predictors of hypothyroidism: a 13-year, longitudinal study of a community-based cohort using current immunoassay techniques. J Clin Endocrinol Metab 95(3):1095–1104
Katznelson L, Laws ER, Melmed S, Molitch ME, Hassan Murad M, Utz A, Wass JAH (2014) Acromegaly: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 99(11):3933–3951
Tita P, Ambrosio MR, Scollo C, Carta A, Gangemi P, Bondanelli M, Vigneri R, Degli Uberti EC, Pezzino V (2005) High prevalence of differentiated thyroid carcinoma in acromegaly. Clin Endocrinol (Oxf) 63(2):161–167
Acknowledgments
This manuscript has not been financially supported by any organization. All the authors have no financial relationship to disclose.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
Marcos Manavela is a Medical Advisor in Novartis. The rest of the authors declare no conflict of interest.
Rights and permissions
About this article
Cite this article
Manavela, M., Vigovich, C., Danilowicz, K. et al. Thyroid autoimmune disorders in patients with acromegaly. Pituitary 18, 912–915 (2015). https://doi.org/10.1007/s11102-015-0670-5
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11102-015-0670-5